RESEARCH-USE BIOSIMILAR ANTIBODY
Carotuximab
Monoclonal antibody · IgG1
Carotuximab (TRC105) is a IgG1 monoclonal antibody that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions.
TARGETCD105
YMonoclonal antibody
CATALOGSC-BS-679
CATALOG NUMBERSC-BS-679
MOLECULAR WEIGHTApprox. 144.8 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Carotuximab (TRC105) is a IgG1 monoclonal antibody that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions.
Carotuximab is a recombinant research-use antibody directed against CD105.